Vendor description
This vendor hasn't published their own description yet. It will appear here once they claim this profile and add it from their dashboard.
At a glance
- Global CRO positioned around on-time Phase II/III delivery with notable oncology and complex indication coverage.
- Services: Full-service CRO, Cell & gene therapy, Patient enrollment
- Coverage: Global · Mixed
- Therapeutic focus: Oncology, Cell and gene therapy, Neurology, Cardiology
- Scale: Global studies with strong specialist and private-CRO posture
Company fit
Best suited for
Sponsors prioritising timeline discipline,mid-market fit,and complex therapeutic depth without defaulting to mega-CRO scale.
Study fit
Best suited for sponsors prioritising timeline discipline,mid-market fit,and complex therapeutic depth without defaulting to mega-cro…
Core strengths
- Strong time-to-milestone positioning
- Broad therapeutic coverage
- Sponsor loyalty/repeat business messaging
Considerations
- Public evidence is primarily corporate-site claims
- Scale profile appears below top-tier mega-CROs
Key facts
- Category
- Full-service CRO
- Geography
- Global
- Service model
- Full-service
- HQ
- Switzerland
Publications
Reviewed vendor articles, separate from independent ratings.
Browse the publications library